![James V. Desiderio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
James V.
Desiderio worked as an Executive Director & Head-Program Management at Idenix Pharmaceuticals LLC, a Principal at Bristol Myers Squibb Co., Gilead Sciences, Inc., and Cubist Pharmaceuticals LLC.
He also served as Senior Vice President-Regulatory & Quality at Acceleron Pharma, Inc. from 2007 to 2021.
Desiderio received his undergraduate degree from Long Island University and his graduate and undergraduate degrees from the College of Veterinary Medicine.
Former positions of James V. Desiderio
| Companies | Position | End |
|---|---|---|
| ACCELERON PHARMA INC. | General Counsel | 2021-11-30 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| IDENIX PHARMACEUTICALS INC | Director/Board Member | - |
Training of James V. Desiderio
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Veterinary Medicine
 College of Veterinary Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- James V. Desiderio
